Advisor Group’s Novavax NVAX Stock Holding History

Advisor Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$28K	Sell	7,100 -75	-1%	-$325	﹤0.01%	3773
2019 Q3	$35K	Buy	7,175 +4,755	+196%	+$26K	﹤0.01%	3631
2019 Q2	$14K	Buy	2,420 +1,897	+363%	+$14.9K	﹤0.01%	4189
2019 Q1	$6K	Buy	523 +72	+16%	+$2.27K	﹤0.01%	4604
2018 Q4	$17K	Buy	451 +134	+42%	+$5.19K	﹤0.01%	3922
2018 Q3	$12K	Buy	317 +103	+48%	+$2.9K	﹤0.01%	4190
2018 Q2	$6K	Sell	214 -70	-25%	-$2.37K	﹤0.01%	4308
2018 Q1	$12K	Sell	284 -230	-45%	-$9.24K	﹤0.01%	3979
2017 Q4	$13K	Hold	514	–	–	﹤0.01%	3949
2017 Q3	$12K	Sell	514 -105	-17%	-$2.35K	﹤0.01%	3875
2017 Q2	$14K	Buy	619 +5	+0.8%	+$98	﹤0.01%	3734
2017 Q1	$16K	Buy	614 +352	+134%	+$9.68K	﹤0.01%	3498
2016 Q4	$7K	Sell	262 -93	-26%	-$2.71K	﹤0.01%	3786
2016 Q3	$15K	Sell	355 -3,419	-91%	-$441K	﹤0.01%	3335
2016 Q2	$547K	Buy	+3,774	New	+$433K	0.01%	871

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Advisor Group's NVAX Position: Q4 2019 in Review

Advisor Group reduced its Novavax (NVAX) stake by 1% in Q4 2019, selling an estimated $325 and leaving 7,100 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #3773.

Advisor Group first reported a position in NVAX in Q2 2016 and has held it in 15 quarters since. The position peaked at $547K in Q2 2016. 77 funds tracked by Wall St. Rank hold NVAX as of Q4 2019.

Advisor Group held 7,100 shares of Novavax worth $28K as of Q4 2019.
Advisor Group sold 75 Novavax shares in Q4 2019, an estimated $325.
Novavax made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3773 holding.
Advisor Group first reported a position in Novavax in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Novavax position peaked at $547K in Q2 2016.
77 funds tracked by Wall St. Rank held Novavax as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.